2019 ESC/EAS Guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk

The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC)

Research output: Contribution to journalReview article

Original languageEnglish
Pages (from-to)111-188
Number of pages78
JournalEuropean Heart Journal
Volume41
Issue number1
DOIs
Publication statusPublished - Jan 1 2020

Keywords

  • Apolipoprotein B
  • Cholesterol
  • Dyslipidaemias
  • Familial hypercholesterolaemia
  • Guidelines
  • High-density lipoproteins
  • Lipoprotein remnants
  • Lipoprotein(a)
  • Low-density lipoproteins
  • Total cardiovascular risk
  • Treatment (adherence)
  • Treatment (drugs)
  • Treatment (lifestyle)
  • Triglycerides
  • Very low-density lipoproteins

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) (2020). 2019 ESC/EAS Guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk. European Heart Journal, 41(1), 111-188. https://doi.org/10.1093/eurheartj/ehz455